Lonza Group Ag PE Ratio 2012-2024 | LZAGY

Current and historical p/e ratio for Lonza Group Ag (LZAGY) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lonza Group Ag PE ratio as of June 12, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Lonza Group Ag PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-11 70.12 0.00
2024-12-31 58.76 0 0.00
2024-06-30 54.24 0 0.00
2023-12-31 41.44 0 0.00
2023-06-30 58.78 0 0.00
2022-12-31 48.01 0 0.00
2022-06-30 52.12 0 0.00
2021-12-31 81.48 0 0.00
2021-06-30 69.15 0 0.00
2020-12-31 62.40 0 0.00
2020-06-30 51.19 0 0.00
2019-12-31 35.26 0 0.00
2019-06-30 32.66 0 0.00
2018-12-31 24.75 0 0.00
2018-06-30 25.42 0 0.00
2017-12-31 25.59 0 0.00
2017-06-30 20.50 0 0.00
2016-12-31 13.95 0 0.00
2016-06-30 13.31 0 0.00
2015-12-31 12.88 0 0.00
2015-06-30 10.57 0 0.00
2014-12-31 8.74 0 0.00
2014-06-30 8.43 0 0.00
2013-12-31 7.17 0 0.00
2013-06-30 5.67 0 0.00
2012-12-31 3.91 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $51.916B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $237.401B 28.55
Boston Scientific (BSX) United States $145.814B 36.50
Stryker (SYK) United States $145.229B 30.37
EssilorLuxottica (ESLOY) France $130.605B 0.00
Medtronic (MDT) Ireland $113.492B 16.09
Haleon (HLN) United Kingdom $49.556B 28.23
ResMed (RMD) United States $36.981B 27.78
Agilent Technologies (A) United States $33.778B 22.02
GE HealthCare Technologies (GEHC) United States $33.476B 15.89
Terumo (TRUMY) Japan $27.213B 35.35
Koninklijke Philips (PHG) Netherlands $22.201B 15.96
Insulet (PODD) United States $21.367B 83.87
Zimmer Biomet Holdings (ZBH) United States $18.451B 11.85
Baxter (BAX) United States $16.093B 12.02
Smith & Nephew SNATS (SNN) United Kingdom $13.187B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.325B 22.01
Lantheus Holdings (LNTH) United States $5.545B 13.99
Prestige Consumer Healthcare (PBH) United States $4.207B 18.80
Perrigo (PRGO) Ireland $3.746B 9.49
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.428B 15.61
ICU Medical (ICUI) United States $3.258B 24.02
Envista Holdings (NVST) United States $3.198B 26.58
GN Store Nord (GNNDY) Denmark $2.319B 19.20
QuidelOrtho (QDEL) United States $2.021B 13.90
LeMaitre Vascular (LMAT) United States $1.839B 41.10
AtriCure (ATRC) United States $1.600B 0.00
Acuren (TIC) United States $1.308B 0.00
Neogen (NEOG) United States $1.220B 15.61
AdaptHealth (AHCO) United States $1.187B 12.05
BioLife Solutions (BLFS) United States $1.107B 0.00
Green Thumb Industries (GTBIF) United States $1.061B 23.86
Phibro Animal Health (PAHC) United States $0.993B 12.70
Kestra Medical Technologies (KMTS) United States $0.963B 0.00
InMode (INMD) Israel $0.888B 8.95
CeriBell (CBLL) United States $0.657B 0.00
Evolus (EOLS) United States $0.656B 0.00
Capricor Therapeutics (CAPR) United States $0.637B 0.00
Owens & Minor (OMI) United States $0.616B 5.11
Maravai LifeSciences Holdings (MRVI) United States $0.576B 0.00
Curaleaf Holdings (CURLF) Canada $0.547B 0.00
Valneva SE (VALN) France $0.523B 0.00
Tilray Brands (TLRY) Canada $0.419B 0.00
Surmodics (SRDX) United States $0.416B 0.00
SNDL (SNDL) Canada $0.355B 0.00
VAREX IMAGING (VREX) United States $0.351B 12.92
Aurora Cannabis (ACB) Canada $0.342B 60.90
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Canopy Growth (CGC) Canada $0.281B 0.00
Viemed Healthcare (VMD) United States $0.268B 22.60
Sanuwave Health (SNWV) United States $0.265B 0.00
Cerus (CERS) United States $0.262B 0.00
ZimVie (ZIMV) United States $0.258B 11.75
Sanara MedTech (SMTI) United States $0.255B 0.00
Cresco Labs (CRLBF) United States $0.251B 0.00
Quanterix (QTRX) United States $0.240B 0.00
OraSure Technologies (OSUR) United States $0.219B 0.00
Biote (BTMD) United States $0.216B 6.08
Brainsway (BWAY) Israel $0.216B 57.10
TriSalus Life Sciences (TLSI) United States $0.208B 0.00
Omeros (OMER) United States $0.208B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.189B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.18
Verano Holdings (VRNOF) United States $0.180B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.143B 0.00
FitLife Brands (FTLF) United States $0.134B 16.51
Jin Medical (ZJYL) China $0.109B 0.00
MacroGenics (MGNX) United States $0.098B 0.00
Veru (VERU) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
Fonar (FONR) United States $0.090B 11.60
Quipt Home Medical (QIPT) United States $0.089B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Agape ATP (ATPC) $0.077B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.067B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Zynex (ZYXI) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
Modular Medical (MODD) United States $0.043B 0.00
Nephros (NEPH) United States $0.043B 57.29
United-Guardian (UG) United States $0.038B 13.02
Rockwell Medical (RMTI) United States $0.033B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Safety Shot (SHOT) United States $0.018B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00